Monsanto Growth Ventures has co-led the first round disclosed by Pairwise Plants, an agricultural gene-editing startup helmed by an ex-Monsanto vice-president.

US-based agricultural gene editing technology developer Pairwise Plants closed a $25m series A round on Tuesday co-led by Monsanto Growth Ventures, a corporate venturing subsidiary of agrochemical producer Monsanto.

The round was co-led with healthcare-focused investment firm Deerfield Management. The company has not previously disclosed funding.

Pairwise is working on agricultural gene modification technology to help alleviate pressures in the global food chain. It has licensed base editing technology created at Harvard University’s Department of Chemistry and Chemical Biology by…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?